Regional Injection of CAR-T Cells for the Treatment of Refractory and Recurrent Diffuse Large B Cell Lymphoma: A Case Report

Regional Injection of CAR-T Cells for the Treatment of Refractory and Recurrent Diffuse Large B Cell Lymphoma: A Case Report

BackgroundLymphoma is a common hematological malignancy with many subtypes and considerable heterogeneity. Traditional treatments include chemotherapy, radiotherapy, and surgery. Patients with relapsed, refractory or advanced stage lymphoma have a dismal prognosis. In recent years, chimeric antigen...

Full description

Bibliographic Details
Main Authors: Yan-Hui Wei, Yu-Zhuo He, Xiao-Yan Lin, Fu-Xian Ren, Hong-Bin Zhu, Ying Cheng, Zhen Nan, Zheng-Biao Liu, Jing-Ya Yu, Xue-Jun Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
chimeric antigen receptor T cells
diffuse large B cell lymphoma
refractory recurrence
regional injection
case report
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.00333/full

Internet

https://www.frontiersin.org/article/10.3389/fcell.2020.00333/full

Similar Items